"Prevalence of Markers for Hepatitis B Virus and HIV-1 among Drug Injectors in London: Injecting Careers, Positivity and Risk Behaviour."

According to the authors' abstract of an article published in Addiction, "Concerns about the risks of HIV infection among drug injectors have eclipsed concerns about the prevalence and transmission of hepatitis, and in particular hepatitis B virus infection. Findings are reported from surveys undertaken with two separate community-recruited samples of drug injectors in London collected in 1992 (n = 505) and in 1993 (n = 507). Anonymized confirmed resting of saliva shows 51.5% of drug injectors in 1992 and 47.9% in 1993 to be antibody positive to the core antigen of hepatitis B virus (anti-HBc). Approximately half of the drug injectors confirmed as anti-HBc positive were unaware that...

Want to see the full article?

• Purchase this article for only $3.00